Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
Still depressed after antidepressants? There are several factors to consider, including brain circuit differences, inflammation, genetics and metabolism, or a missed diagnosis, and there are newer options like ketamine or esketamine, TMS, ECT, psilocybin-assisted therapy, VNS, and augmentation strategies.
See below for what qualifies as treatment resistant, how to pair therapy, sleep, exercise and nutrition with meds, and the exact next steps to discuss with your doctor, including when to seek urgent help.
If you've tried antidepressants and still feel stuck, you're not alone. Up to one-third of people with depression don't respond fully to standard medications. This is often called treatment-resistant depression (TRD).
It can feel frustrating, confusing, and exhausting. You may wonder: Why aren't the meds working? Is something wrong with me?
The short answer: probably not. Depression is complex. Your brain may simply need a different approach.
In this article, we'll explain:
Most traditional antidepressants target brain chemicals like serotonin, norepinephrine, and dopamine. These medications can be very effective—but not for everyone.
Here's why they may not work:
Depression is not a single disease. It's likely a group of related conditions with different causes, including:
If your depression isn't primarily caused by a serotonin imbalance, a serotonin-based medication may not help much.
Research shows that depression involves changes in brain networks—not just chemical levels. Regions that regulate mood, motivation, and reward may be underactive or poorly connected.
Standard medications don't directly "rewire" these circuits. That's where newer approaches come in.
Some people with depression have higher levels of inflammation. In these cases, traditional antidepressants may have limited effects because they don't target inflammatory pathways.
This is an active area of research.
Your body may metabolize medications too quickly—or too slowly. Genetic differences in liver enzymes can affect how well a drug works or how strong side effects feel.
Pharmacogenetic testing is sometimes used to guide treatment choices.
Doctors generally define treatment-resistant depression as:
If this sounds like you, it doesn't mean you're out of options. It means your care plan may need to expand beyond standard treatments.
Researchers have been working intensely on new approaches. Some are FDA-approved for certain cases. Others are still considered experimental but show strong promise.
Here are the most important options.
One of the most significant breakthroughs in decades.
Ketamine affects glutamate, a brain chemical involved in learning and brain plasticity. Unlike traditional antidepressants, it can:
Esketamine (a nasal spray version) is FDA-approved for treatment-resistant depression under medical supervision.
Ketamine is one of the most widely discussed experimental depression treatments for treatment resistant patients, though it is now partially mainstream.
TMS is a non-invasive brain stimulation therapy.
TMS is FDA-approved and often used after medication failures.
ECT has been around for decades and remains one of the most effective treatments for severe depression.
Modern ECT is done under anesthesia and is carefully controlled.
It's not experimental—but it's often considered after other options fail.
Psilocybin (the active compound in certain mushrooms) is being studied in clinical trials for depression.
Early research suggests:
This remains experimental and is not widely available outside research settings. It should only be pursued legally and under medical supervision.
VNS involves implanting a small device that stimulates the vagus nerve.
It's less common but can be life-changing for some patients.
Researchers are exploring:
These approaches are still under investigation but may help certain subgroups.
Sometimes the solution isn't replacing a medication—it's adding to it.
Examples:
These are well-established strategies under psychiatric supervision.
Medication alone isn't always enough.
For many patients, combining treatments works best:
Depression affects the whole system—brain, body, behavior, and environment.
Sometimes persistent depression symptoms may overlap with:
If treatments haven't worked, it may be worth reviewing the original diagnosis.
Before your next doctor's appointment, consider using Ubie's free AI-powered Depression symptom checker to get a clearer picture of what you're experiencing and help you ask more informed questions about your treatment options.
If you feel stuck:
You deserve a thoughtful, individualized plan.
It's important not to sugarcoat this:
Treatment-resistant depression can be difficult. Some people require multiple adjustments before finding relief. It may take time.
But here's the hopeful truth:
Your brain isn't broken. It may simply need a different approach.
If you experience:
You should seek immediate medical care or contact emergency services.
Depression can be serious—and sometimes life-threatening. Speaking to a doctor or mental health professional is essential if symptoms worsen or become dangerous.
If you're still depressed despite medication, it doesn't mean you've failed treatment. It means your treatment may need to evolve.
The growing field of experimental depression treatments for treatment resistant patients offers real hope—from ketamine and TMS to emerging psychedelic therapies and brain stimulation techniques.
Start by reviewing your symptoms, speak openly with your doctor, and explore all evidence-based options available to you.
Progress may take time—but new doors are opening.
(References)
* Riva, M. A., Cocco, M., Musso, T., Saredi, S., Tassinari, V., Bonavita, L., & Calza, L. (2022). Treatment-Resistant Depression: Pathophysiological Mechanisms and Novel Therapeutic Approaches. *Brain sciences*, *12*(7), 896.
* Chen, C., Xiao, F., Song, Z., Lu, H., Huang, R., & Wu, X. (2022). The neurobiological mechanisms of treatment-resistant depression: Current understanding and future directions. *Psychiatry research*, *318*, 114942.
* Mrazek, D. A. (2021). The path toward personalized medicine for patients with treatment-resistant depression. *Journal of Clinical Psychopharmacology*, *41*(4), 335–343.
* Reiff, C. M., Ma, Z., & Correll, C. U. (2023). Psychedelics for the treatment of mental health disorders: a systematic review. *Molecular psychiatry*, *28*(8), 3163–3183.
* Krystal, J. H., Sanacora, G., Duman, R. S., Iosifescu, D. V., & Nestler, E. J. (2022). Glutamate, ketamine, and the future of rapid-acting treatments for depression. *Biological psychiatry*, *91*(3), 220–222.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.